Companies » Company Overview » Astrazeneca Pharma India Ltd.
 
 

Astrazeneca Pharma India Ltd.

  • BSE: 506820
  • Sector: Health care
  • NSE: ASTRAZEN
  • ISIN Code: INE203A01020
  • BSE

    LIVE

    15:48 | 30 Jun

  • 1197.20
  • 11.80
    (1.00%)
  • Open
    1152.15
  • HIGH
    1220.00
  • LOW
    1152.15
  • NSE

    LIVE

    15:59 | 30 Jun

  • 1192.00
  • 7.30
    (0.62%)
  • Open
    1192.00
  • HIGH
    1219.95
  • LOW
    1182.10
 
bse
15:48 PM,30th Jun 2015
1197.20
11.80 (1.00%)
Previous Close 1185.40
Volume 6593
52-Week high 1299.00
52-Week low 785.30
P/E -
Mkt Cap.(Rs cr) 2993
Bid Price 0.00
Bid Quantity 0.00
Offer Price 1197.20
Offer Quantity 185.00
NSE
15:59 PM,30th Jun 2015

1192.00
7.30 (0.62%)
Bse
15:48 PM,30th Jun 2015

1197.20
11.80 (1.00%)
nse
15:59 PM,30th Jun 2015
1192.00
7.30 (0.62%)
Previous Close 1184.70
Volume 20909
52-Week high 1298.80
52-Week low 781.00
P/E -
Mkt Cap.(Rs cr) 2993
Bid Price 0.00
Bid Quantity 0.00
Offer Price 1192.00
Offer Quantity 795.00

Astrazeneca Pharma India Ltd. (ASTRAZEN) - Company Information

Astrazeneca Pharma India formerly known as Astra-IDL (AIL), a joint venture of Astra Zeneca, UK and Hinduja controlled IDL is a market leader in local anesthetics with xylocaine. The, UB's 100% subsidiary, UB Biotek, has tied up with the Company to market its newly-patented anti-obesity nutraceutical. The herbal product, Hydroxycitrisol, extracted from garcinia (kokum), is one of two UB technologies to recently get US patents. It is due to complete clinical tests at AIL and may hit the marke... [More]

Key Fundamentals
Market Cap (Rs cr) 2,993
EPS - TTM (Rs)

[*S]

-
P/E Ratio (x)

[*S]

-
Face Value (Rs) 2
Latest Dividend (%) 175.00
Latest Dividend Date 09 Jul 2012
Dividend Yield (%) 0.00
Book Value / Share (Rs)

[*S]

60.30
P/B Ratio (x)

[*S]

19.85
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
1152.15
1220.00
Week Low/High
1125.00
1278.00
Month Low/High
895.10
1299.00
YEAR Low/High
785.30
1299.00
All TIME Low/High
3.75
2649.00
Peer Group
Company Last Change(%)
Strides Arcolab 1111.15 1.38
Shilpa Medicare 867.85 -1.23
Indoco Remedies 361.20 -0.21
Astrazeneca Phar 1197.20 1.00
Suven Life Scie. 233.35 3.09
Sequent Scien. 710.75 2.86
Vinati Organics 521.15 1.18
Returns
Period Astrazeneca Phar Sensex NIFTY
1 Week -3.49% -0.08% -0.16%
1 Month 24.42% -0.17% -0.77%
3 Month 31.77% -0.70% -1.46%
6 Month 49.04% 1.41% 1.48%
1 Year 5.37% 9.31% 9.95%
3 Year -34.83% 59.39% 58.53%
Period Astrazeneca Phar Sensex NIFTY
1 Week -4.08% -0.08% -0.16%
1 Month 23.90% -0.17% -0.77%
3 Month 31.34% -0.70% -1.46%
6 Month 48.55% 1.41% 1.48%
1 Year 4.98% 9.31% 9.95%
3 Year -35.12% 59.39% 58.53%
Financial Results
Particulars (Rs cr) Mar 2015 Mar 2014 %Chg
Net Sales 168.55 114.15 47.66
Other Income 1.35 15.31 -91.18
Total Income 169.9 129.46 31.24
Total Expenses 127.75 129.05 -1.01
Operating Profit 42.15 0.4 10437.5
Net Profit 38.13 -2.57 1583.66
Equity Capital 5 5 -
SHAREHOLDING PATTERN
As on Mar 2015
Company information
Chairman : D E Udwadia
Director : K S Shah
Director : Ian Brimicombe
Director : Narayan K Seshadri
Director : Justin Ooi
Managing Director : Sanjay Murdeshwar
Company Secretary : Anantha Murthy N
Additional Director : Rebekah Martin
AUDITOR: BSR & Co LLP
IND NAME: Pharmaceuticals - Multinational
HOUSE NAME: MNC Associate
Registered office
Avishkar, Off Bellary Road Hebbal,
Bangalore,Karnataka-560024
Ph: 91-80-67748000
E-mail: comp.secy@astrazeneca.com
URL: http://www.astrazeneca/india.com

Quick Links

 
Quick Links for Astrazeneca Pharma India

Back to Top